no human clinical trials have been published
If your cells become resistant to insulin, they dont process sugar as well as they should
Potinital GLP-1 use to pevent the clinical progression of PAD in individuals with type 2 diabetes
Research Background AHK-Cu has been investigated in preclinical dermatological research for its effects on dermal papilla cells and hair follicle cycling
After acute subcutaneous treatment with 1 g/kg dose of exenatide 1 h before S1, food intake decreased to the same very low level in all meal schedule conditions in S1, completely erasing the previously observed anticipatory effect
It is important to note that while these medications can be taken long-term, there is no official requirement to take them "forever." Treatment duration should be determined collaboratively between patient and physician based on individual circumstances, treatment response, and evolving health needs